Breastfed infants of HIV-exposed mothers get a probiotic
Part of Immune system & allergy, Infections clinical trials.
This study gives a specific probiotic (from B. infantis) to babies born without HIV to see if it can improve the baby’s early immune health. It focuses on babies who are HIV-exposed because their mother has HIV and plans to exclusively breastfeed for the first 6 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Mother is 18 years or older and can sign the consent forms
- Mother has HIV and started HIV treatment before the third trimester of pregnancy
- Mother plans to exclusively breastfeed the baby for the first 6 months
- Baby was born HIV-negative, at full term (at least 37 weeks), and weighed over 2.4 kg
- Baby does not have serious illness (like sepsis) and does not have current TB or a known TB contact at home
- Baby should not take other probiotics or prebiotics, and there were no major delivery problems or serious birth issues
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if pasteurized donor human milk is a safe and acceptable option for infants exposed to HIV. It may help families who cannot or choose not to breastfeed.
This study looks at whether giving probiotics to healthy newborns changes the bacteria in their stool. It may help researchers understand early gut health, but it is only for babies who meet specific health and timing requirements.
This trial tests an experimental vaccine for babies who were exposed to HIV while in the womb but are not infected. Mothers must be living with HIV, on treatment, and deliver by C-section at the study hospital in Soweto.
This study tests whether giving a probiotic (a 'good' bacteria) to babies who received antibiotics shortly after birth can help their developing gut and immune system. Participants will receive a daily probiotic or placebo for about 6 weeks, and their health will be monitored.
This trial studies ways to protect babies who were exposed to HIV before birth but are not infected themselves. It aims to find better interventions to prevent severe infections in these infants.
This study tests whether giving a special antibody treatment to babies living with HIV, shortly after birth, can help their immune system fight the virus better. It aims to improve their long-term health.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.